POINT-OF-CARE TESTING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-88594 | Pharmaceuticals And Medical
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Point-of-Care Testing Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL POINT-OF-CARE TESTING MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL POINT-OF-CARE TESTING MARKET
7.1 GLOBAL POINT-OF-CARE TESTING MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 BioSpectrum Asia
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Fosun Pharma
16.3 Johnson & Johnson
16.4 Sysmex Corporation
16.5 HemoCue India
16.6 DiaSys India
16.7 Siemens Healthineers India
16.8 Operon Biotech
16.9 Roche Diagnostics India
16.10 Abbott Laboratories Inc
16.11 Beckman Coulter Inc
16.12 Becton
16.13 Acrongenomics Inc
16.14 Dickinson and Company
16.15 Alere Inc
16.16 Instrumentation Laboratory
16.17 PTS Diagnostics
16.18 Abaxis Inc
16.19 Medtronic
16.20 Accriva Diagnostics
16.21 OPTI Medical
16.22 Sienco Inc
16.23 AccuBioTech Co Ltd
16.24 ACON Laboratories Inc
16.25 bioMerieux SA
16.26 Biomerica Inc
16.27 Atlas Genetics Ltd
16.28 Alfa Scientific Designs Inc
16.29 Alpha Scientific
16.30 Bio-Rad Laboratories Inc
16.31 Medica Corporation
16.32 Nova Biomedical
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeBlood Glucose Testing Kits
Cardiometabolic Monitoring Kits
Infectious Disease Testing Kits
Cholesterol Testing Kits
Pregnancy and Fertility Tests Kits
Tumor/Cancer Markers
Urinalysis Testing Kits
Cholesterol Test Strips
Hematology Testing Kits
Drugs of Abuse Testing Kits
Fecal Occult Testing Kits
Rapid Coagulation Testing Kits
Others
By Application
Cardiology
Critical Care
Diabetes
Endocrinology
Liver Diseases
Maternal Fetal
Neonatology
Companies
BioSpectrum Asia
Fosun Pharma
Johnson & Johnson
Sysmex Corporation
HemoCue India
DiaSys India
Siemens Healthineers India
Operon Biotech
Roche Diagnostics India
Abbott Laboratories Inc
Beckman Coulter Inc
Becton
Acrongenomics Inc
Dickinson and Company
Alere Inc
Instrumentation Laboratory
PTS Diagnostics
Abaxis Inc
Medtronic
Accriva Diagnostics
OPTI Medical
Sienco Inc
AccuBioTech Co Ltd
ACON Laboratories Inc
bioMerieux SA
Biomerica Inc
Atlas Genetics Ltd
Alfa Scientific Designs Inc
Alpha Scientific
Bio-Rad Laboratories Inc
Medica Corporation
Nova Biomedical
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.